HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Korro Bio (NASDAQ:KRRO) and maintained a $100 price target, as stated by analyst Mitchell Kapoor.
May 21, 2024 | 10:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Korro Bio and maintained a $100 price target, indicating continued confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $100 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100